Rezolute Correlations
| RZLT Stock | USD 3.35 0.02 0.59% |
The current 90-days correlation between Rezolute and Eledon Pharmaceuticals is 0.37 (i.e., Weak diversification). The correlation of Rezolute is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Rezolute Correlation With Market
Modest diversification
The correlation between Rezolute and DJI is 0.21 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Rezolute and DJI in the same portfolio, assuming nothing else is changed.
Rezolute |
Moving together with Rezolute Stock
| 0.77 | A | Agilent Technologies | PairCorr |
| 0.72 | ME | 23Andme Holding | PairCorr |
| 0.61 | VANI | Vivani Medical Earnings Call This Week | PairCorr |
| 0.75 | DNLI | Denali Therapeutics | PairCorr |
| 0.85 | VCEL | Vericel Corp Ord | PairCorr |
| 0.86 | VCYT | Veracyte | PairCorr |
| 0.68 | VRDN | Viridian Therapeutics Downward Rally | PairCorr |
| 0.71 | VRPX | Virpax Pharmaceuticals | PairCorr |
Moving against Rezolute Stock
| 0.67 | DVAX | Dynavax Technologies | PairCorr |
| 0.37 | VALN | Valneva SE ADR | PairCorr |
| 0.5 | VRTX | Vertex Pharmaceuticals | PairCorr |
| 0.46 | EDSA | Edesa Biotech | PairCorr |
| 0.43 | VNDA | Vanda Pharmaceuticals | PairCorr |
| 0.38 | VRNA | Verona Pharma PLC | PairCorr |
| 0.37 | CDTTW | Conduit Pharmaceuticals | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Rezolute Stock performing well and Rezolute Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Rezolute's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| FRLN | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| ELDN | 2.74 | (0.25) | 0.00 | (0.26) | 0.00 | 4.71 | 18.63 | |||
| CLNN | 2.84 | 0.09 | 0.02 | (0.01) | 4.10 | 5.93 | 17.63 | |||
| RPHM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| LRMR | 3.64 | (1.13) | 0.00 | (0.58) | 0.00 | 5.82 | 22.70 |
Rezolute Corporate Management
| Raj MD | VP Development | Profile | |
| Michael Deperro | Senior Development | Profile | |
| LLM JD | Chief Officer | Profile | |
| Gopal MBBS | Senior Development | Profile | |
| MD MBA | Director Affairs | Profile | |
| Daron Evans | Chief Officer | Profile | |
| Erin OBoyle | Senior Operations | Profile |